title: Increased susceptibility to complement attack due to down-regulation of decay-accelerating factor/CD55 in dysferlin-deficient muscular dystrophy.
abstract: Dysferlin is expressed in skeletal and cardiac muscles. However, dysferlin deficiency results in skeletal muscle weakness, but spares the heart. We compared intraindividual mRNA expression profiles of cardiac and skeletal muscle in dysferlin-deficient SJL/J mice and found down-regulation of the complement inhibitor, decay-accelerating factor/CD55, in skeletal muscle only. This finding was confirmed on mRNA and protein levels in two additional dysferlin-deficient mouse strains, A/J mice and Dysf-/- mice, as well as in patients with dysferlin-deficient muscular dystrophy. In vitro, the absence of CD55 led to an increased susceptibility of human myotubes to complement attack. Evidence is provided that decay-accelerating factor/CD55 is regulated via the myostatin-SMAD pathway. In conclusion, a novel mechanism of muscle fiber injury in dysferlin-deficient muscular dystrophy is demonstrated, possibly opening therapeutic avenues in this to date untreatable disorder.
authors.affiliation: Myology Research Group, Department of Neurology, Charité University Hospital, Berlin, Germany.
authors.forename: Katrin
authors.initials: K
authors.lastname: Wenzel
authors.forename: Joanna
authors.initials: J
authors.lastname: Zabojszcza
authors.forename: Miriam
authors.initials: M
authors.lastname: Carl
authors.forename: Semjon
authors.initials: S
authors.lastname: Taubert
authors.forename: Antje
authors.initials: A
authors.lastname: Lass
authors.forename: Claire L
authors.initials: CL
authors.lastname: Harris
authors.forename: Mengfatt
authors.initials: M
authors.lastname: Ho
authors.forename: Herbert
authors.initials: H
authors.lastname: Schulz
authors.forename: Oliver
authors.initials: O
authors.lastname: Hummel
authors.forename: Norbert
authors.initials: N
authors.lastname: Hubner
authors.forename: Karl Josef
authors.initials: KJ
authors.lastname: Osterziel
authors.forename: Simone
authors.initials: S
authors.lastname: Spuler
mesh_terms: D000328:Adult; D000818:Animals; D018958:CD55 Antigens / Q000032:analysis / Q000502:physiology*; D003165:Complement System Proteins / Q000276:immunology*; D015536:Down-Regulation; D000073939:Dysferlin; D005260:Female; D006801:Humans; D008297:Male; D008565:Membrane Proteins / Q000172:deficiency*; D051379:Mice; D008810:Mice, Inbred C57BL; D008875:Middle Aged; D018485:Muscle Fibers, Skeletal / Q000473:pathology*; D018482:Muscle, Skeletal / Q000737:chemistry; D009136:Muscular Dystrophies / Q000276:immunology* / Q000473:pathology; D055435:Myostatin; D051900:Smad3 Protein / Q000032:analysis / Q000502:physiology; D016212:Transforming Growth Factor beta / Q000032:analysis / Q000502:physiology
chemical_list: D018958:CD55 Antigens; C497505:Dysf protein, mouse; D000073939:Dysferlin; C525911:MSTN protein, human; D008565:Membrane Proteins; C525912:Mstn protein, mouse; D055435:Myostatin; C497790:SMAD3 protein, human; D051900:Smad3 Protein; D016212:Transforming Growth Factor beta; D003165:Complement System Proteins